NCT06741098View on ClinicalTrials.gov

A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 15, 2028

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

NCR100

Subjects will receive multiple intra-articular NCR100 injections.

OTHER

0.9% Normal saline

Subjects will receive multiple intra-articular 0.9% Normal saline injections.

Sponsors
All Listed Sponsors
collaborator

Shanghai 6th People's Hospital

OTHER

lead

Nuwacell Biotechnologies Co., Ltd.

INDUSTRY